Effects of Fexofenadine Hydrochloride in a Guinea Pig Model of Antigen-Induced Rhinitis
- 7 September 2005
- journal article
- Published by S. Karger AG in Pharmacology
- Vol. 75 (2), 76-86
- https://doi.org/10.1159/000087124
Abstract
Allergic rhinitis is an inflammatory disease of the nasal mucosa, induced by histamine, leukotrienes, and other substances released from mast cells. Fexofenadine hydrochloride, the active metabolite of terfenadine, is a novel, nonsedating antiallergic drug having H1 receptor antagonistic activity. Fexofenadine is effective for the treatment of allergic rhinitis. However, its mechanism of action in attenuating nasal congestion has not yet been elucidated. Therefore, we first examined the effects of fexofenadine on a guinea pig model of antigen-induced rhinitis. We also evaluated the effects of mepyramine, zafirlukast and ramatroban in this model; these drugs are an H1 receptor antagonist, a selective leukotriene antagonist and a selective thromboxane antagonist, respectively. Rhinitis was induced by ovalbumin (OVA) instillation into the nasal cavity of animals that had been sensitized by two earlier OVA injections (s.c. and i.p.). The nasal airway resistance was measured for 45 min after the challenge. Fexofenadine hydrochloride (20 mg/kg) and terfenadine (20 mg/kg) administered orally 70 min prior to the challenge significantly inhibited (fexofenadine, p < 0.001, terfenadine, p < 0.05) the increase in nasal airway resistance. Ramatroban (30 mg/kg) administered orally 60 min prior to the challenge also significantly inhibited (p < 0.05) the increase in nasal airway resistance. In contrast, mepyramine (3 mg/kg i.v.) and zafirlukast (3 mg/kg p.o.) failed to reduce the increase in nasal airway resistance. These results suggest that thromboxane may be involved in the increase in the nasal airway resistance in this model. Accordingly, fexofenadine may reduce the increase in nasal airway resistance by inhibiting the release of chemical mediators, including thromboxane, that are involved in the increase in nasal airway resistance in this model.Keywords
This publication has 38 references indexed in Scilit:
- Effects of fexofenadine on the early response to nasal allergen challengeAnnals of Allergy, Asthma & Immunology, 2002
- Markedly Increased Nasal Blockage by Intranasal Leukotriene D4 in an Experimental Allergic Rhinitis Model: Contribution of Dilated Mucosal Blood VesselsThe Japanese Journal of Pharmacology, 2001
- Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitisJournal of Allergy and Clinical Immunology, 1998
- Effect of Oxatomide on Experimental Allergic Rhinitis in Guinea PigsThe Japanese Journal of Pharmacology, 1998
- FexofenadineDrugs, 1998
- Pathophysiology of perennial allergic rhinitisAllergy, 1997
- Effects of a Specific Cysteinyl Leukotriene Antagonist, Pranlukast, on Antigen-Induced Cysteinyl Leukotriene-Mediated Rhinitis in Guinea PigsThe Japanese Journal of Pharmacology, 1997
- Effects of Thromboxane A2 Receptor Antagonist (Bay u 3405) on Nasal Symptoms after Antigen Challenge in Sensitized Guinea PigsInternational Archives of Allergy and Immunology, 1996
- The study of chemical mediators in the patients with allergic rhinitis. 2) Histamine, leukotriene and kinins in the nasal secretion during dual phase response.Nippon Jibiinkoka Gakkai Kaiho, 1991
- Antiallergic Effects of Terfenadine on Immediate Type Hypersensitivity ReactionsImmunopharmacology and Immunotoxicology, 1987